Insights on the Infectious Disease Diagnostics Global Market to 2026 – Increasing Prevalence of Infectious Diseases is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Infectious Disease Diagnostics Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.

The infectious disease diagnostics market is poised to grow by $13.94 billion during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period.

The report on the infectious disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of infectious diseases, the development of novel drugs, and the increasing adoption of POC.

The infectious disease diagnostics market analysis includes the end-user segment and geographic landscape. This study identifies the increase in M & A as one of the prime reasons driving the infectious disease diagnostics market growth during the next few years. Also, increasing investment in research and development and the emergence of new patterns of infectious diseases will lead to sizable demand in the market.

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Genetic Signatures Ltd.
  • Grifols SA
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • Meril Life Sciences Pvt. Ltd.
  • OraSure Technologies Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
  • Vela Diagnostics

The report on the infectious disease diagnostics market covers the following areas:

  • Infectious disease diagnostics market sizing
  • Infectious disease diagnostics market forecast
  • Infectious disease diagnostics market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Key Topics Covered:

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition

3.2 Market segment analysis

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

5 Market Segmentation by End-user

6 Customer Landscape

6.1 Customer landscape overview

7 Geographic Landscape

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

8.4 Market trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/c91ro1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900